Nanostrategies: The Future Medicine for Fighting Cancer Progression and Drug Resistance 2.0-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanostrategies: The Future Medicine for Fighting Cancer Progression and Drug Resistance 2.0

Published:2022-11-21 Issue:22 Volume:23 Page:14486
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Beretta Giovanni Luca^ORCID

Abstract

The attractiveness of the nanomaterials research field has persisted [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/23/22/14486/pdf

Reference14 articles.

1. Cancer nanomedicine: Progress, challenges and opportunities;Nat. Rev. Cancer,2017

2. Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis;Int. J. Nanomed.,2022

3. Khan, M.M., and Torchilin, V.P. (2022). Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors. Cancers, 14.

4. Sharifi, M., Cho, W.C., Ansariesfahani, A., Tarharoudi, R., Malekisarvar, H., Sari, S., Bloukh, S.H., Edis, Z., Amin, M., and Gleghorn, J.P. (2022). An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment. Cancers, 14.

5. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment;Adv. Drug Deliv. Rev.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP